Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 14.26%1.37B | 18.36%913.1M | 6.64%426.46M | 15.64%1.69B | 11.25%1.2B | 9.86%771.47M | 4.94%399.89M | -29.09%1.46B | -35.79%1.08B | -39.96%702.2M |
| Refunds of taxes and levies | 204.27%34.83M | 318.02%24.57M | 817.75%14.41M | 126.74%29.72M | 0.24%11.45M | -57.30%5.88M | -64.52%1.57M | -47.84%13.11M | -52.66%11.42M | -31.92%13.76M |
| Cash received relating to other operating activities | 13.70%20.92M | -19.39%7.56M | -55.45%3.53M | -0.34%25.97M | -7.11%18.4M | 42.35%9.37M | 223.54%7.92M | 31.44%26.06M | 38.93%19.81M | -8.39%6.58M |
| Cash inflows from operating activities | 16.02%1.43B | 20.15%945.22M | 8.55%444.4M | 16.33%1.74B | 10.81%1.23B | 8.88%786.72M | 5.53%409.38M | -28.74%1.5B | -35.41%1.11B | -39.63%722.55M |
| Goods services cash paid | 6.32%1.09B | 16.72%768.22M | 27.37%398.51M | 24.13%1.42B | 25.59%1.02B | 31.43%658.17M | 19.90%312.86M | -23.13%1.14B | -29.66%813.13M | -36.85%500.79M |
| Staff behalf paid | 15.55%172.13M | 14.38%116.08M | 12.81%63.02M | 19.10%199.46M | 21.01%148.97M | 25.89%101.49M | 34.43%55.87M | 2.28%167.48M | -0.65%123.11M | -7.72%80.62M |
| All taxes paid | -6.70%27.5M | -6.61%19.06M | -42.91%7.25M | -8.09%43.54M | -13.41%29.48M | -3.09%20.41M | 31.97%12.7M | 14.03%47.38M | 27.24%34.04M | 20.35%21.06M |
| Cash paid relating to other operating activities | 2.01%59.68M | -6.98%34.68M | -29.53%16.9M | -6.61%78.66M | -4.39%58.5M | 10.22%37.28M | 23.31%23.98M | 18.63%84.22M | 9.58%61.19M | -9.17%33.82M |
| Cash outflows from operating activities | 6.91%1.35B | 14.77%938.05M | 19.80%485.68M | 20.68%1.74B | 21.98%1.26B | 28.45%817.35M | 22.27%405.41M | -18.20%1.44B | -24.29%1.03B | -31.95%636.3M |
| Net cash flows from operating activities | 372.29%80.41M | 123.42%7.17M | -1,139.40%-41.28M | -92.97%4.02M | -138.18%-29.53M | -135.52%-30.63M | -92.95%3.97M | -83.20%57.23M | -78.16%77.36M | -67.06%86.25M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -11.90%27.66M | -33.80%17.27M | -70.15%3.85M | -78.62%69.42M | -89.97%31.39M | -87.59%26.09M | -74.21%12.9M | -76.82%324.64M | -72.82%312.83M | -68.06%210.2M |
| Cash received from returns on investments | -14.64%944.26K | -14.63%944.26K | ---- | 5.83%3.66M | -68.01%1.11M | 30.52%1.11M | 123.98%494.07K | -25.04%3.46M | 0.20%3.46M | -67.59%847.42K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 276.40%2.27M | -65.74%90.4K | ---- | -96.25%1.09M | -88.16%603.89K | -94.63%263.87K | ---- | 1,069.14%29.21M | 927.30%5.1M | 2,844.52%4.91M |
| Cash received relating to other investing activities | -96.23%798K | -95.45%798K | ---- | -52.63%10.07M | 62.63%21.16M | 467.56%17.52M | -52.64%600.08K | 220.67%21.25M | 162.48%13.01M | 83.41%3.09M |
| Cash inflows from investing activities | -41.63%31.67M | -57.53%19.1M | -72.48%3.85M | -77.75%84.24M | -83.77%54.26M | -79.47%44.98M | -72.84%13.99M | -73.24%378.55M | -71.17%334.4M | -66.94%219.05M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -9.88%114.42M | -15.92%82.4M | -47.91%36.72M | -42.41%160.91M | -34.92%126.96M | -24.21%98.01M | 10.59%70.5M | 103.42%279.41M | 144.29%195.08M | 89.27%129.32M |
| Cash paid to acquire investments | 194.69%28.29M | 49.46%8.37M | 191.79%8.17M | -90.60%17M | -94.62%9.6M | -95.69%5.6M | -86.00%2.8M | -88.09%180.81M | -86.80%178.31M | -83.97%130M |
| Cash paid relating to other investing activities | 6.67%800K | --800K | ---- | -83.41%900K | -79.91%750K | ---- | ---- | 22.07%5.43M | 18.50%3.73M | 386.69%2.43M |
| Cash outflows from investing activities | 4.52%143.51M | -11.61%91.57M | -38.76%44.89M | -61.60%178.81M | -63.59%137.31M | -60.42%103.61M | -14.01%73.3M | -71.94%465.64M | -73.70%377.12M | -70.25%261.75M |
| Net cash flows from investing activities | -34.66%-111.84M | -23.62%-72.47M | 30.80%-41.04M | -8.59%-94.57M | -94.38%-83.05M | -37.29%-58.62M | -75.91%-59.3M | 64.44%-87.09M | 84.43%-42.73M | 80.34%-42.7M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | -83.68%5.31M | 1,418.51%5.31M | --5.31M | 1,272.01%33.61M | 3,001.36%32.56M | -66.67%350K | ---- | -45.56%2.45M | -76.67%1.05M | -65.00%1.05M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | --0 | ---- | ---- | 0.00%2.45M | 33.33%1.4M | -66.67%350K | ---- | -45.56%2.45M | -76.67%1.05M | -65.00%1.05M |
| Cash from borrowing | -12.43%179.43M | -13.60%155.43M | 14.59%124.43M | 94.43%284.56M | 74.60%204.9M | 88.66%179.9M | 33.47%108.58M | -29.46%146.35M | -43.44%117.35M | -29.23%95.35M |
| Cash received relating to other financing activities | 117.38%19.86M | --15.68M | --10.2M | -73.42%20.57M | -86.08%9.14M | ---- | ---- | 129.83%77.4M | 297.33%65.66M | 2,686.22%38.09M |
| Cash inflows from financing activities | -17.03%204.61M | -2.12%176.43M | 28.88%139.95M | 49.75%338.75M | 33.98%246.6M | 34.02%180.25M | -11.09%108.58M | -7.92%226.21M | -19.45%184.06M | -3.31%134.49M |
| Borrowing repayment | 175.83%144.65M | 371.08%119.65M | 173.47%69.46M | -29.98%111.13M | -66.96%52.44M | -71.05%25.4M | -69.31%25.4M | -45.68%158.71M | -38.29%158.71M | -41.88%87.75M |
| Dividend interest payment | 51.10%8.02M | 6.88%4.12M | 109.25%2M | 143.33%7.03M | 160.90%5.31M | 708.82%3.86M | 277.76%955.01K | -21.01%2.89M | -39.13%2.03M | -82.26%477.16K |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.62M | --1.29M | ---- |
| Cash payments relating to other financing activities | -17.35%50.71M | -57.77%21.09M | -64.69%6.71M | 36.53%71.98M | 29.43%61.36M | 44.07%49.94M | -52.37%19.01M | -41.01%52.72M | -43.71%47.41M | -24.10%34.66M |
| Cash outflows from financing activities | 70.76%203.38M | 82.91%144.87M | 72.33%78.17M | -11.28%190.14M | -42.78%119.1M | -35.55%79.2M | -63.09%45.36M | -44.36%214.32M | -39.62%208.14M | -38.35%122.89M |
| Net cash flows from financing activities | -99.04%1.23M | -68.77%31.56M | -2.29%61.78M | 1,149.88%148.61M | 629.47%127.5M | 770.86%101.05M | 8,296.11%63.22M | 108.52%11.89M | 79.28%-24.08M | 119.27%11.6M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -196.65%-29.59K | -82.12%93.81K | -107.96%-12.42K | 136.23%549.27K | -102.30%-9.97K | 9.97%524.74K | 137.92%156K | -86.62%232.52K | -75.04%432.82K | 5.09%477.17K |
| Net increase in cash and cash equivalents | -302.78%-30.22M | -373.23%-33.64M | -355.53%-20.56M | 430.61%58.62M | 35.66%14.9M | -77.87%12.31M | -62.52%8.05M | 57.81%-17.73M | 131.70%10.99M | 468.63%55.63M |
| Add:Begin period cash and cash equivalents | 138.02%101.08M | 138.02%101.08M | 138.02%101.08M | -29.45%42.47M | -29.45%42.47M | -29.45%42.47M | -29.45%42.47M | -41.11%60.2M | -41.11%60.2M | -41.11%60.2M |
| End period cash equivalent | 23.52%70.86M | 23.11%67.44M | 59.41%80.52M | 138.02%101.08M | -19.40%57.37M | -52.71%54.78M | -38.15%50.51M | -29.45%42.47M | 5.35%71.18M | 32.94%115.83M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.